Stimulation of whole blood cells from SZ patients with selective TLR agonists results in enhanced release of pro-inflammatory cytokines (including IL-1β, IL-6, IL-8, and TNF-α) (150), further supporting the role of TLRs in regulating neuroinflammation in schizophrenia. The gene discussed is IL1B; the disease is schizophrenia.